How many institutions held OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in Q1 2018?

48 institutional investors reported OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share for Q1 2018. Use the holders table for investor-level position and value details.

Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)

Q: What does CUSIP 690469101 represent in this 13F holders report?

CUSIP 690469101 is the security identifier for OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 690469101

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 134,553,130
Total 13F shares: 7,048,747
Share change: -773,761
Total reported value: $49,828,303
Price per share: $7.07
Number of holders: 48
Value change: -$9,279,532
Number of buys: 35
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP 690469101?
CUSIP 690469101 identifies OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2018
Previous quarter: Q4 2017

Recent filing periods for CUSIP 690469101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	1.1%	1,473,873	$14,547,000	—	31 Dec 2017	13F
BlackRock Finance, Inc.	13F	Company	0.79%	1,063,212	$10,494,000	—	31 Dec 2017	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.5%	672,763	$6,640,000	—	31 Dec 2017	13F
JENNISON ASSOCIATES LLC	13F	Company	0.43%	578,005	$5,705,000	—	31 Dec 2017	13F
Tekla Capital Management LLC	13F	Company	0.4%	535,824	$5,289,000	—	31 Dec 2017	13F
OppenheimerFunds, Inc.	13F	Company	0.32%	424,720	$4,192,000	—	31 Dec 2017	13F
VANGUARD GROUP INC	13F	Company	0.25%	334,066	$3,298,000	—	31 Dec 2017	13F
BAKER BROS. ADVISORS LP	13F	Company	0.25%	333,333	$3,290,000	—	31 Dec 2017	13F
Redmile Group, LLC	13F	Company	0.23%	312,782	$3,087,000	—	31 Dec 2017	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.22%	299,570	$2,957,000	—	31 Dec 2017	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.2%	271,697	$2,682,000	—	31 Dec 2017	13F
Cormorant Asset Management, LP	13F	Company	0.17%	223,972	$2,211,000	—	31 Dec 2017	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.16%	215,347	$2,125,000	—	31 Dec 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.16%	211,100	$2,082,000	—	31 Dec 2017	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.13%	180,674	$1,783,000	—	31 Dec 2017	13F
Casdin Capital, LLC	13F	Company	0.12%	160,000	$1,579,000	—	31 Dec 2017	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.08%	105,470	$1,041,000	—	31 Dec 2017	13F
STATE STREET CORP	13F	Company	0.06%	75,566	$748,000	—	31 Dec 2017	13F
NORTHERN TRUST CORP	13F	Company	0.05%	65,166	$643,000	—	31 Dec 2017	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.04%	49,000	$484,000	—	31 Dec 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.03%	33,949	$335,000	—	31 Dec 2017	13F
MORGAN STANLEY	13F	Company	0.02%	26,657	$264,000	—	31 Dec 2017	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.02%	20,520	$203,000	—	31 Dec 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	20,510	$203,000	—	31 Dec 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.01%	16,889	$167,000	—	31 Dec 2017	13F
Granite Point Capital Management, L.P.	13F	Company	0.01%	15,000	$148,000	—	31 Dec 2017	13F
TD ASSET MANAGEMENT INC	13F	Company	0.01%	13,580	$134,000	—	31 Dec 2017	13F
Bank of New York Mellon Corp	13F	Company	0.01%	13,499	$133,000	—	31 Dec 2017	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.01%	13,145	$131,000	—	31 Dec 2017	13F
Spark Investment Management LLC	13F	Company	0.01%	10,800	$106,000	—	31 Dec 2017	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.01%	10,011	$99,000	—	31 Dec 2017	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	8,900	$88,000	—	31 Dec 2017	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	7,900	$78,000	—	31 Dec 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	0%	6,063	$60,000	—	31 Dec 2017	13F
JPMORGAN CHASE & CO	13F	Company	0%	5,663	$56,000	—	31 Dec 2017	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0%	3,403	$34,000	—	31 Dec 2017	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0%	1,824	$18,000	—	31 Dec 2017	13F
STRS OHIO	13F	Company	0%	1,500	$14,000	—	31 Dec 2017	13F
Legal & General Group Plc	13F	Company	0%	1,098	$11,000	—	31 Dec 2017	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	1,043	$10,294	—	31 Dec 2017	13F
BARCLAYS PLC	13F	Company	0%	801	$8,000	—	31 Dec 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	785	$8,000	—	31 Dec 2017	13F
Parallax Volatility Advisers, L.P.	13F	Company	0%	756	$7,000	—	31 Dec 2017	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	615	$6,000	—	31 Dec 2017	13F
CITIGROUP INC	13F	Company	0%	467	$5,000	—	31 Dec 2017	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	443	$4,000	—	31 Dec 2017	13F
Delpha Capital Management, LLC	13F	Company	0%	314	$3,000	—	31 Dec 2017	13F
UBS Group AG	13F	Company	0%	227	$2,000	—	31 Dec 2017	13F
MEEDER ASSET MANAGEMENT INC	13F	Company	0%	88	$1,000	—	31 Dec 2017	13F

Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q1 2018

As of 31 Mar 2018, Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,048,747 shares. The largest 10 holders included FMR LLC, BlackRock Inc., JENNISON ASSOCIATES LLC, Tekla Capital Management LLC, OppenheimerFunds, Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, DEUTSCHE BANK AG\, DRIEHAUS CAPITAL MANAGEMENT LLC, and BAKER BROS. ADVISORS LP. This page lists 48 institutional shareholders reporting positions in this security for the Q1 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders

Q1 2018 holders

Holder diff

-1

Investor	Q4 2017 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q4 2017 Value $	Q1 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.